Growth Metrics

Emergent BioSolutions (EBS) Retained Earnings (2016 - 2026)

Emergent BioSolutions has reported Retained Earnings over the past 17 years, most recently at -$153.0 million for Q1 2026.

  • For Q1 2026, Retained Earnings fell 2408.2% year-over-year to -$153.0 million; the TTM value through Mar 2026 reached -$153.0 million, down 2408.2%, while the annual FY2025 figure was -$7.5 million, 96.47% up from the prior year.
  • Retained Earnings for Q1 2026 was -$153.0 million at Emergent BioSolutions, down from -$7.5 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $738.7 million in Q4 2022 and troughed at -$212.4 million in Q4 2024.
  • A 5-year average of $25.4 million and a median of -$6.1 million in 2022 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: skyrocketed 4849.18% in 2023 and later crashed 3626.32% in 2024.
  • Year by year, Retained Earnings stood at $738.7 million in 2022, then tumbled by 100.77% to -$5.7 million in 2023, then crashed by 3626.32% to -$212.4 million in 2024, then soared by 96.47% to -$7.5 million in 2025, then tumbled by 1940.0% to -$153.0 million in 2026.
  • Business Quant data shows Retained Earnings for EBS at -$153.0 million in Q1 2026, -$7.5 million in Q4 2025, and -$7.5 million in Q3 2025.